Management of Delirium
The most effective approach to treating delirium is implementing multicomponent non-pharmacological interventions, which reduce delirium incidence by 44% and significantly shorten delirium duration, while pharmacological agents should be reserved only for severe agitation or distressing psychosis that poses safety risks 1, 2.
Non-Pharmacological Management (First-Line)
The cornerstone of delirium treatment involves structured, interdisciplinary interventions that address multiple domains simultaneously 1, 2:
Core Components to Implement:
- Early mobilization: Get patients out of bed and moving as soon as medically feasible
- Cognitive reorientation: Provide clocks, calendars, familiar objects; repeatedly orient to time, place, person
- Sleep hygiene: Minimize nighttime interruptions, reduce noise and light, cluster care activities
- Sensory optimization: Ensure glasses and hearing aids are available and functioning
- Nutrition and hydration: Optimize oral intake, address dehydration promptly
- Pain management: Treat pain adequately without over-sedation
- Family involvement: Encourage familiar faces at bedside, use family photos and voices
These multicomponent programs (HELP, ABCDE bundle, CHOPS, AKTIVER) have the strongest evidence base, with 2026 meta-analyses demonstrating clear superiority over pharmacological approaches 1, 2.
Identify and Treat Underlying Causes
Work through this systematic evaluation:
- Medications: Review and discontinue or reduce anticholinergics, benzodiazepines, opioids, and other deliriogenic drugs 3
- Infections: Check for UTI, pneumonia, sepsis
- Metabolic derangements: Correct electrolytes, glucose, thyroid, hepatic/renal dysfunction
- Hypoxia/hypercapnia: Optimize oxygenation and ventilation
- Withdrawal syndromes: Consider alcohol or benzodiazepine withdrawal 3
- Neurological events: Rule out stroke, seizures, increased intracranial pressure
- Pain and urinary retention: Address these common precipitants
Pharmacological Management (Second-Line Only)
Medications should only be used when patients pose immediate safety risks to themselves or others through severe agitation, or when experiencing distressing hallucinations/delusions 4, 5, 2.
When Pharmacotherapy is Necessary:
Antipsychotics (haloperidol, olanzapine, risperidone, or quetiapine) have the most evidence for symptom reduction 4:
- Start with low doses (e.g., haloperidol 0.5-1 mg)
- Use the lowest effective dose for the shortest duration
- Monitor for extrapyramidal symptoms and QTc prolongation
Critical caveat: Patients on supportive care alone consistently show better remission rates than those on multiple psychotropics. Triple+ drug regimens perform worst across all delirium subtypes 5. Limit the number of psychotropic medications.
Special Populations:
ICU patients requiring sedation: Dexmedetomidine is preferred over benzodiazepines, as it reduces delirium incidence and duration of mechanical ventilation 3, 4. Benzodiazepines should be avoided as they worsen delirium outcomes.
Parkinson's disease patients: Adjust anti-parkinsonian medications first; use antipsychotics only for severe, distressing symptoms due to risk of worsening motor function 6.
Subtype Considerations
Recognize that delirium presents differently:
- Hyperactive: Agitation, hallucinations—more readily identified
- Hypoactive: Lethargy, withdrawal—frequently missed but more persistent 3
- Mixed: Most severe and persistent, often requires more intensive management 5
The hypoactive subtype is commonly misdiagnosed; maintain high clinical suspicion in lethargic patients 3.
Common Pitfalls to Avoid
- Don't assume sedation equals treatment: Sedating delirious patients worsens outcomes
- Don't use benzodiazepines except for alcohol/benzodiazepine withdrawal 3
- Don't pile on multiple psychotropics: More drugs correlate with worse outcomes 5
- Don't miss hypoactive delirium: It's not just agitation and hallucinations
- Don't forget post-delirium follow-up: Patients need cognitive and functional assessment after resolution 7, 8
Monitoring and Follow-Up
Use validated screening tools (CAM-ICU, 4AT, CAM) for systematic detection 2. All elderly patients without prior dementia who experience delirium require cognitive and functional follow-up, as delirium increases dementia risk and causes persistent decline 1, 7, 8.